P-43 Effect of the treatment withCA2 anti-TNF monoclonal antibody on the bone marrow (BM) progenitor cell reserve and function and stromal cell function in patients with myelodysplastic syndrome (MDS). A study of the Greek mds study group
Helen Α. Papadaki(University of Crete), George D. Eliopoulos(University of Crete), Nora‐Athina Viniou, Panayiotis Tsaftaridis, Charalampos Pontikoglou(University of Crete), Argiris Symeonidis(University of Patras), George Katrinakis(University of Crete), Emilia Stavroulaki, Michalis Voulgarelis, Anna Boula(University of Crete)
Cited by 0
Related Papers
Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2
|Nature Genetics|2003|389
Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide
|Journal of Clinical Oncology|2007|279
Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis
|Annals of the Rheumatic Diseases|2007|154